Nippon Shinyaku Co.,Ltd.
4516 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 京都市南区吉祥院西ノ庄門口町１４番地
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Nippon Shinyaku Co., Ltd. is a distinguished Japanese company specializing in pharmaceutical manufacturing and functional food development. With a commitment to high quality and originality, Nippon Shinyaku has been at the forefront of innovation since its inception. The company focuses on delivering exceptional products that enhance health and well-being, driven by a dedication to research and development. Its dual business model highlights the integration of pharmaceutical expertise into functional foods, ensuring that customers receive superior quality that stands out in the market. With a strong emphasis on sustainability and a passion for improving lives, Nippon Shinyaku continues to evolve while remaining deeply rooted in its foundational values.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-04 06:16 |
Inside Information Statement
臨時報告書
|
Japanese | 27.7 KB | |
| 2025-06-24 06:23 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
| 2025-06-24 06:22 |
Internal Control over Financial Reporting
内部統制報告書－第162期(2024/04/01－2025/03/31)
|
Japanese | 26.1 KB | |
| 2025-06-24 06:18 |
Annual Report
有価証券報告書－第162期(2024/04/01－2025/03/31)
|
Japanese | 1.6 MB | |
| 2024-11-14 02:12 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
| 2024-11-14 02:11 |
Interim Report
半期報告書－第162期(2024/04/01－2025/03/31)
|
Japanese | 233.5 KB | |
| 2024-07-01 04:04 |
Inside Information Statement
臨時報告書
|
Japanese | 29.3 KB | |
| 2024-06-28 04:07 |
Internal Control over Financial Reporting
内部統制報告書－第161期(2023/04/01－2024/03/31)
|
Japanese | 23.3 KB | |
| 2024-06-28 04:01 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
| 2024-06-28 03:58 |
Annual Report
有価証券報告書－第161期(2023/04/01－2024/03/31)
|
Japanese | 1.5 MB | |
| 2024-02-14 02:06 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
| 2024-02-14 02:05 |
Quarterly Report
四半期報告書－第161期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 244.8 KB | |
| 2023-11-14 01:59 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
| 2023-11-14 01:59 |
Quarterly Report
四半期報告書－第161期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 262.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
D.Western Therapeutics Institute, Inc. | Japan | 4576 | |
|
EARNZ PLC | United Kingdom | EARN | |
|
Eevia Health Plc | Finland | EEVIA | |
|
Egetis Therapeutics | Sweden | EGTX | |
|
EIKEN CHEMICAL CO.,LTD. | Japan | 4549 | |
|
Eisai Co., Ltd. | Japan | 4523 | |
|
ELARIS AG | Germany | ELS | |
|
Enervit | Italy | ENV | |
|
Enorama Pharma AB | Sweden | ERMA | |
|
Enzymatica AB | Sweden | ENZY |